PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30278111-1	2019	BACKGROUND AND AIM: L-carnitine (L-CA) has been used therapeutically to treat hepatic encephalopathy with hyperammonemia, but the mechanism by which L-CA contributes to ammonia detoxification in the brain is still unclear.	Carnitine	20-31	protein tyrosine phosphatase receptor type C	Homo sapiens	33-37	
30278111-1	2019	BACKGROUND AND AIM: L-carnitine (L-CA) has been used therapeutically to treat hepatic encephalopathy with hyperammonemia, but the mechanism by which L-CA contributes to ammonia detoxification in the brain is still unclear.	Carnitine	20-31	protein tyrosine phosphatase receptor type C	Homo sapiens	149-153